|
|
40
|
|
|
66742
|
|
|
LAFENAC 25MG/ML INJ (LDP/AHI) DICLOFENAC POTASSIUM
|
|
|
DICLOFENAC POTASSIUM
|
|
|
LAFENAC
|
|
|
10X3ML
|
|
|
B
|
|
|
45.34
|
|
|
4.53
|
|
|
25MG/ML
|
|
|
INJECTION
|
|
|
0
|
|
|
AMP
|
|
|
LDP
|
|
|
LABDHI PHARMA
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
10
|
|
|
No
|
|
|
28080492
|
|
|
OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|